ReviewBeilstein journal of nanotechnology2021

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors.

Nikola Geskovski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.